# WeedOUT

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/weedout

- Industry: Biotechnology
- Headquarters: Israel
- Website: www.weedout-ibs.com
- Total disclosed funding: $12M
- Latest round: Series A (Feb 20, 2024)
- Investors on record: 7

## About

Based in Ness Ziona, Israel, and founded in 2016 by co-CEOs Efrat Lidor Nili and Orly Noivirt-Brik, WeedOUT Ltd., a.k.a. WeedOUT is an Ag-Tech company that offers bioherbicide solutions to control the population of resistant weeds. The company's technology also reduces the need for toxic herbicides. In February 2024, WeedOUT Ltd. raised USD 8.1 million in a Series A funding led by Fulcrum Global Capital with participation from Bunge Ventures and Clay Capital.

WeedOUT develops a biological herbicide that targets resistant weeds using a novel approach. The company’s solution involves a unique weed pollen that competes with natural weed pollen, preventing the fertilization of ovules and resulting in non-viable seeds. This method reduces the production of viable seeds, thus controlling weed populations.

The company plans to use its proceeds from February 2024 funding to further expand its field trials in multiple regions in the U.S.

## Funding rounds

- Series A, Feb 20, 2024, $8.1M — Clay Capital, Fulcrum Global Capital, Bunge Ventures
- Series A, Feb 20, 2020, $4.2M — Syngenta Ventures, CreditEase Fintech Investment Fund, iVentures Asia Ltd, ZORA Ventures, Fulcrum Global Capital
- Seed, Apr 7, 2017 — CreditEase Fintech Investment Fund, iVentures Asia Ltd

## Investors

- CreditEase Fintech Investment Fund (https://capitalatlas.ai/funds/creditease-fintech-investment-fund) — Seed, Series A
- iVentures Asia Ltd — Seed, Series A
- Syngenta Ventures (https://capitalatlas.ai/funds/syngenta-ventures) — Series A
- ZORA Ventures (https://capitalatlas.ai/funds/zora-ventures) — Series A
- Fulcrum Global Capital (https://capitalatlas.ai/funds/fulcrum-global-capital) — Series A
- Clay Capital (https://capitalatlas.ai/funds/clay-capital) — Series A
- Bunge Ventures — Series A